| Hereditary Neurological Disorders | Lifetime | 2 | GB 1 | 99.76 |
| Genetic Neurodegenerative Diseases | Lifetime | 31 | GB 10 | 99.65 |
| Neurological diseases and metabolism | Lifetime | 14 | GB 4 | 99.69 |
| RNA regulation and disease | Lifetime | 69 | GB 6 | 98.94 |
| Mitochondrial Function and Pathology | Lifetime | 226 | GB 22 | 99.08 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 235 | GB 39 | 99.16 |
| Genomics and Rare Diseases | Lifetime | 135 | GB 15 | 98.57 |
| Metabolism and Genetic Disorders | Lifetime | 511 | GB 39 | 98.31 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 340 | GB 45 | 98.15 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 174 | GB 22 | 98.18 |
| Alzheimer's disease research and treatments | Lifetime | 765 | GB 63 | 98.11 |
| Cerebrovascular and genetic disorders | Lifetime | 104 | GB 16 | 95.83 |
| Hermeneutics and Narrative Identity | Lifetime | 723 | GB 118 | 90.87 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 540 | GB 56 | 94.59 |
| Nuclear Receptors and Signaling | Lifetime | 516 | GB 33 | 93.53 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 483 | GB 47 | 92.83 |
| Porphyrin Metabolism and Disorders | Lifetime | 683 | GB 64 | 91.97 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 1 | GB 1 | 99.56 |
| Neurological diseases and metabolism | 2021-2025 | 6 | GB 1 | 98.35 |
| Mitochondrial Function and Pathology | 2021-2025 | 41 | GB 6 | 97.94 |
| RNA regulation and disease | 2021-2025 | 14 | GB 1 | 97.15 |
| Genomics and Rare Diseases | 2021-2025 | 46 | GB 5 | 98.02 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 45 | GB 6 | 97.52 |
| Hereditary Neurological Disorders | 2021-2025 | 16 | GB 6 | 96.62 |
| Metabolism and Genetic Disorders | 2021-2025 | 197 | GB 24 | 91.90 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 471 | GB 41 | 94.74 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 217 | GB 22 | 92.89 |
| Cellular transport and secretion | 2021-2025 | 259 | GB 20 | 86.55 |
| Cerebrovascular and genetic disorders | 2021-2025 | 51 | GB 10 | 88.09 |
| Muscle Physiology and Disorders | 2021-2025 | 451 | GB 41 | 88.29 |
| Lysosomal Storage Disorders Research | 2021-2025 | 294 | GB 27 | 88.36 |
| Genomic variations and chromosomal abnormalities | 2021-2025 | 430 | GB 38 | 83.11 |
| Neuromodulation and Treatments for Neurological Disorders | 2021-2025 | 903 | GB 61 | 87.89 |
| Glycogen Storage Diseases and Myoclonus | 2021-2025 | 124 | GB 10 | 84.79 |
| Nuclear Receptors and Signaling | 2021-2025 | 193 | GB 14 | 77.21 |
| Metalloenzymes and iron-sulfur proteins | 2021-2025 | 616 | GB 27 | 52.13 |
| Neurological and metabolic disorders | 2021-2025 | 630 | GB 19 | 45.49 |
